The ALPS International Sector Dividend Dogs ETF (IDOG) has been upgraded to a 'Buy' rating due to its attractive 4.2% dividend yield, solid dividend growth, and low concentration risks. Since inception, IDOG has outperformed the MSCI EAFE benchmark with a 1.1% annualized excess return and has shown strong recent performance. The fund offers balanced exposure across sectors and countries with a diversified portfolio of 50 large-cap international stocks, making it a compelling choice for income-focused investors. An alternative fund, DIVI, offers lower expenses, higher liquidity, and slightly better risk-adjusted returns, providing investors with options based on their preferences.
Nyxoah announced preliminary Q3 2026 revenue of €9.2 million, up 19% sequentially, driven by a 29% increase in U.S. sales. The company submitted a PMA supplement to the FDA to expand its Genio device indication for patients with complete concentric c...
ASML Holding N.V. announced recent transactions under its ongoing share buyback program, repurchasing a total of 233,867 shares between October 12 and October 16, 2026. The shares were bought back at weighted average prices ranging from €1,444.83 to ...
The Phase 3 ALKIVIA trial demonstrated that efgartigimod significantly improves symptoms in patients with autoimmune myositis, including immune-mediated necrotizing myopathy (IMNM) and dermatomyositis (DM). Patients showed meaningful clinical improve...
In 2025, Berkshire Hathaway, led by Greg Abel, received $479 million in dividends from its $1.3 billion investment in American Express. This highlights the value of holding strong dividend-paying stocks for steady income. Retail investors can apply s...
Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...
